006280 — GC Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
KR₩2tn
Enterprise Value
KR₩3tn
Revenue
KR₩2tn

Annual balance sheet for GC Biopharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	202,935	112,306	55,506	22,563	49,372
Net Total Accounts Receivable
Net Total Receivables	423,991	409,498	451,005	404,841	405,299
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,095,621	980,438	1,039,149	1,201,834	1,370,388
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	899,847	930,822	952,703	915,826	960,461
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,462,145	2,525,537	2,643,314	2,743,876	2,971,095
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	552,883	540,738	868,917	769,475	1,145,803
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,187,374	1,197,415	1,343,078	1,491,231	1,753,618
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	1,274,771	1,328,122	1,300,236	1,252,645	1,217,477
Total Liabilities & Shareholders' Equity	2,462,145	2,525,537	2,643,314	2,743,876	2,971,095
Total Common Shares Outstanding